BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 15217995)

  • 1. Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility.
    Mulders AG; Laven JS; Eijkemans MJ; de Jong FH; Themmen AP; Fauser BC
    Hum Reprod; 2004 Sep; 19(9):2036-42. PubMed ID: 15217995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.
    Laven JS; Mulders AG; Visser JA; Themmen AP; De Jong FH; Fauser BC
    J Clin Endocrinol Metab; 2004 Jan; 89(1):318-23. PubMed ID: 14715867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism.
    Eldar-Geva T; Margalioth EJ; Gal M; Ben-Chetrit A; Algur N; Zylber-Haran E; Brooks B; Huerta M; Spitz IM
    Hum Reprod; 2005 Jul; 20(7):1814-9. PubMed ID: 15802320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome.
    Das M; Gillott DJ; Saridogan E; Djahanbakhch O
    Hum Reprod; 2008 Sep; 23(9):2122-6. PubMed ID: 18550512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
    Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J
    Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
    Pierre A; Peigné M; Grynberg M; Arouche N; Taieb J; Hesters L; Gonzalès J; Picard JY; Dewailly D; Fanchin R; Catteau-Jonard S; di Clemente N
    Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum anti-Müllerian hormone expression in women with premature ovarian failure.
    Méduri G; Massin N; Guibourdenche J; Bachelot A; Fiori O; Kuttenn F; Misrahi M; Touraine P
    Hum Reprod; 2007 Jan; 22(1):117-23. PubMed ID: 16954410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of anti-Müllerian hormone in the classification of anovulatory infertility.
    Lie Fong S; Schipper I; Valkenburg O; de Jong FH; Visser JA; Laven JS
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():75-9. PubMed ID: 25666342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study.
    van Rooij IA; Broekmans FJ; Scheffer GJ; Looman CW; Habbema JD; de Jong FH; Fauser BJ; Themmen AP; te Velde ER
    Fertil Steril; 2005 Apr; 83(4):979-87. PubMed ID: 15820810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of measuring anti-Mullerian hormone in women with anovulatory polycystic ovary syndrome undergoing laparoscopic ovarian diathermy.
    Amer SA; Li TC; Ledger WL
    Hum Reprod; 2009 Nov; 24(11):2760-6. PubMed ID: 19640893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a sensitive enzyme immunoassay for anti-Müllerian hormone and the evaluation of potential clinical applications in males and females.
    Al-Qahtani A; Muttukrishna S; Appasamy M; Johns J; Cranfield M; Visser JA; Themmen AP; Groome NP
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):267-73. PubMed ID: 16117813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Mullerian hormone (AMH): what do we still need to know?
    La Marca A; Broekmans FJ; Volpe A; Fauser BC; Macklon NS;
    Hum Reprod; 2009 Sep; 24(9):2264-75. PubMed ID: 19520713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-mullerian hormone as a marker of ovarian reserve.
    Tremellen KP; Kolo M; Gilmore A; Lekamge DN
    Aust N Z J Obstet Gynaecol; 2005 Feb; 45(1):20-4. PubMed ID: 15730360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Müllerian hormone and anti-Müllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women.
    Kevenaar ME; Themmen AP; Laven JS; Sonntag B; Fong SL; Uitterlinden AG; de Jong FH; Pols HA; Simoni M; Visser JA
    Hum Reprod; 2007 Jun; 22(6):1547-54. PubMed ID: 17337470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Müllerian inhibiting substance and disrupted folliculogenesis in polycystic ovary syndrome.
    Wang JG; Nakhuda GS; Guarnaccia MM; Sauer MV; Lobo RA
    Am J Obstet Gynecol; 2007 Jan; 196(1):77.e1-5. PubMed ID: 17240243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable serum levels of anti-Müllerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women.
    Tsepelidis S; Devreker F; Demeestere I; Flahaut A; Gervy Ch; Englert Y
    Hum Reprod; 2007 Jul; 22(7):1837-40. PubMed ID: 17485437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone.
    Lie Fong S; Laven JS; Hakvoort-Cammel FG; Schipper I; Visser JA; Themmen AP; de Jong FH; van den Heuvel-Eibrink MM
    Hum Reprod; 2009 Apr; 24(4):982-90. PubMed ID: 19153092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.
    Bayrak A; Terbell H; Urwitz-Lane R; Mor E; Stanczyk FZ; Paulson RJ
    Fertil Steril; 2007 Apr; 87(4):870-5. PubMed ID: 17224152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.